The planned analytical study is designed to strengthen manufacturing characterization of EL-22 as development of the ...
Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for autoimmune diseases, including type 1 diabetes ...
Indian pharma finds conventional analytics insufficient, turns to AI for actionable insights: Nandita Vijayasimha, Bengaluru Friday, July 10, 2026, 12:15 Hrs [IST] India's pharmac ...
Henny Zijlstra, Chief Commercial Officer of Ardena, discusses the integrated CDMO model, Ardena’s new laboratory in New ...
Today, the integration of AI and digital technologies is fundamentally rewriting the rules of R&D—serving as the ultimate breakthrough to shatter industry bottlenecks and drive unprecedented ...
A repurposed small molecule originally developed for spinal cord injury has demonstrated the ability to address multiple ...
Denali co-founder and CEO Ryan Watts, Ph.D., to deliver opening plenary address at 2026 AAIC in London on July 12, 2026Presentation will ...
Under the two-year project timeline, researchers will spend the first year optimizing vaccine candidates and evaluating their ...
Cascade Prodrug Inc. and Uneedle are advancing their collaboration to evaluate CPD100, Cascade’s first-in-class hypoxia-targeted therapeutic, in neovascular, or wet, age-related macular degeneration.
South Korea's major biotech conglomerates are accelerating strategic partnerships in China, positioning the country as a key ...
Opus Genetics, Inc. (Nasdaq: IRD) (the "Company", "Opus Genetics" or "Opus"), a clinical-stage biopharmaceutical company developing gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results